Acute and Substantial Vision Loss After Pembrolizumab Immunotherapy for Bladder Cancer. Pan WW, Waters I, Yousif J, Reichert ZR, et al. JAMA Ophthalmol 2025 Dec 11. doi: 10.1001/jamaophthalmol.2025.5068.

Read + Share

Amedeo Smart

Independent Medical Education

Pan WW, Waters I, Yousif J, Reichert ZR, et al. Acute and Substantial Vision Loss After Pembrolizumab Immunotherapy for Bladder Cancer. JAMA Ophthalmol 2025 Dec 11. doi: 10.1001/jamaophthalmol.2025.5068.
PMID: 41379437